Jung-Yun Lee (Junsik Park)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Regulatory T Cells

Sentinel Lymph Node

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Yonsei medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Jung-Yun Lee, Jung Chul Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Park
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 + TILs based on BRCA1/2 mutation status in epithelial ovarian cancers. Journal for immunotherapy of cancer 12 (7) (2024)
Jung-Yun Lee, Jung Chul Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Park
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 + TILs based on BRCA1/2 mutation status in epithelial ovarian cancers. Journal for immunotherapy of cancer 12 (7) (2024)
Seung Hyuck Jeon, Gihoon You, Jung-Yun Lee, You-Seung Chung, Kyungjin Park, Hyunjoo Kim, Jaehyoung Jeon, Youngkwang Kim, Woo-Chan Son, Da Som Jeong, Eui-Cheol Shin, Jung-Yun Lee, Dai Hoon Han, Jaeho Jung, Su-Hyung Park
Anti-4-1BB×PD-L1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD-1 Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Byungsoo Ahn, Damin Moon, Hyun Soo Kim, Chung Lee, Nam Hoon Cho, Heung-Kook Choi, Dongmin Kim, Jung-Yun Lee, Eun Ji Nam, Dongju Won, Hee Jung An, Sun Young Kwon, Su-Jin Shin, Hye Ra Jung, Dohee Kwon, Heejung Park, Milim Kim, Yoon Jin Cha, Hyunjin Park, Yangkyu Lee, Songmi Noh, Yong-Moon Lee, Sung-Eun Choi, Ji Min Kim, Sun Hee Sung, Eunhyang Park
Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer. Nature communications 15 (1) (2024)
Byungsoo Ahn, Damin Moon, Hyun Soo Kim, Chung Lee, Nam Hoon Cho, Heung-Kook Choi, Dongmin Kim, Jung-Yun Lee, Eun Ji Nam, Dongju Won, Hee Jung An, Sun Young Kwon, Su-Jin Shin, Hye Ra Jung, Dohee Kwon, Heejung Park, Milim Kim, Yoon Jin Cha, Hyunjin Park, Yangkyu Lee, Songmi Noh, Yong-Moon Lee, Sung-Eun Choi, Ji Min Kim, Sun Hee Sung, Eunhyang Park
Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer. Nature communications 15 (1) (2024)
Jung-Yun Lee, Jung Chul Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Park
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 + TILs based on BRCA1/2 mutation status in epithelial ovarian cancers. Journal for immunotherapy of cancer 12 (7) (2024)
Byungsoo Ahn, Damin Moon, Hyun Soo Kim, Chung Lee, Nam Hoon Cho, Heung-Kook Choi, Dongmin Kim, Jung-Yun Lee, Eun Ji Nam, Dongju Won, Hee Jung An, Sun Young Kwon, Su-Jin Shin, Hye Ra Jung, Dohee Kwon, Heejung Park, Milim Kim, Yoon Jin Cha, Hyunjin Park, Yangkyu Lee, Songmi Noh, Yong-Moon Lee, Sung-Eun Choi, Ji Min Kim, Sun Hee Sung, Eunhyang Park
Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer. Nature communications 15 (1) (2024)
Jung-Yun Lee, Jung Chul Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Park
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 + TILs based on BRCA1/2 mutation status in epithelial ovarian cancers. Journal for immunotherapy of cancer 12 (7) (2024)
Jung-Yun Lee, Hyun Woong Cho, Myong Cheol Lim, Chel Hun Choi, Jung-Yun Lee
OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer. Future oncology (London, England) (2024)
Byungsoo Ahn, Damin Moon, Hyun Soo Kim, Chung Lee, Nam Hoon Cho, Heung-Kook Choi, Dongmin Kim, Jung-Yun Lee, Eun Ji Nam, Dongju Won, Hee Jung An, Sun Young Kwon, Su-Jin Shin, Hye Ra Jung, Dohee Kwon, Heejung Park, Milim Kim, Yoon Jin Cha, Hyunjin Park, Yangkyu Lee, Songmi Noh, Yong-Moon Lee, Sung-Eun Choi, Ji Min Kim, Sun Hee Sung, Eunhyang Park
Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer. Nature communications 15 (1) (2024)
Jung-Yun Lee, Jung Bok Lee, Myong Cheol Lim, Byoung-Gie Kim, Jae-Weon Kim, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim, Sang Yoon Park, Jung-Yun Lee, null null
Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D. Journal for immunotherapy of cancer 11 (10) (2023)
Jung-Yun Lee, Jung Chul Kim, Miran Lee, JooHyang Lee, Yoo-Na Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Su-Hyung Park, Jung-Yun Lee
Frequency of peripheral PD-1 + regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer. British journal of cancer (2023)
Seung Hyuck Jeon, Minyong Kang, Minwoo Jeon, You-Seung Chung, A Reum Kim, Yong Joon Lee, Eui-Soon Kim, Heejin Nam, Jung-Yun Lee, Jung-Yun Lee, Eui-Cheol Shin, Seong Il Seo, Su-Hyung Park
CEACAM1 marks highly suppressive intratumoral regulatory T cells for targeted depletion therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jung-Yun Lee, Ha Young Woo, Yoo-Na Kim, Jung-Yun Lee, Eun Ji Nam, Sang-Wun Kim, Sunghoon Kim, Young-Tae Kim, Eunhyang Park, Je-Gun Joung, Jung-Yun Lee
Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer. Cancers 14 (9) (2022)
Jung-Yun Lee, Myong Cheol Lim, Jae Kwan Lee, Dae Hoon Jeong, Se Ik Kim, Min Chul Choi, Byoung Gie Kim, Jung-Yun Lee
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial. Journal of gynecologic oncology 33 (2) (2021)
Kyung Jin Eoh, Jung-Yun Lee, Hye Min Kim, Maria Lee, Young-Tae Kim
Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs. Yonsei medical journal 62 (4) (2021)
Jung-Yun Lee, Kyung Jin Eoh, Eun Ji Nam, Sunghoon Kim, Sang-Wun Kim, Young-Tae Kim, Jung-Yun Lee
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer. Yonsei medical journal 61 (4) (2020)
Minsuk Kwon, Chang Gon Kim, Hoyoung Lee, Hyunsoo Cho, Youngun Kim, Eung Chang Lee, Seong Jin Choi, Jung-Yun Lee, In-Ho Seo, Bjarne Bogen, Ik-Chan Song, Deog-Yeon Jo, Jin Seok Kim, Su-Hyung Park, Inhak Choi, Yoon Seok Choi, Eui-Cheol Shin
PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (7) (2020)
Jung-Yun Lee, Jung-Yun Lee, Sunghoon Kim
How to use immune checkpoint inhibitor in ovarian cancer? Journal of gynecologic oncology 30 (5) (2019)
Jung-Yun Lee, Minsuk Kwon, Kyung Hwan Kim, Seon-Hui Hong, Seok-Gu Kang, Ju Hyung Moon, Su-Hyung Park, Jong Hee Chang, Eui-Cheol Shin
Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (8) (2019)
A Reum Kim, Jung-Yun Lee, Jong Hoon Kim, Jeong-Eun Kwak, Youngran Cho, Hyojin Lee, Moonsup Jeong, Su-Hyung Park, Eui-Cheol Shin
Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity. Immune network 18 (5) (2018)